pros and cons tirzepatide of microdosing GLP-1 agonists—using doses below FDA-approved levels for T2D or obesity—is rapidly gaining traction as an off-label strategy to improve tolerability, tailor titration, manage costs Microdosing tirzepatide The infographic compares 10 commonly

It is a normal physiological response, and it does not mean the medication has stopped working

According to the Evaluate consultancys 2026 Preview report, Mounjaro and Zepbound are projected to collectively generate more than $45 billion in global sales in 2026, overtaking Mercks Keytruda to become the worlds best-selling drug

are the most impressive weight-loss tools weve ever seen

doi: 10.1152/ajpgi.00175.2021 15 WenSNguyenTGongMYuanXWangCJinJet al

Protein has grown everywhere, and now fiber and probiotics are definitely the new hot thing. Reeves pointed to recent CPG launches from Danone and Nestl, featuring products that are high in protein (20-23 grams/serving) plus fiber